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8J. Pept. Sci. 2014; 20:Directing peptide crystallization through
curvature control of nanotubes‡Frédéric Gobeaux,a,b,c Christophe Tarabout,b Nicolas Fay,a,b
Cristelle Meriadec,b Melinda Ligeti,d David-Alexandre Buisson,d
Jean-Christophe Cintrat,d Franck Artznerb** and Maïté Paternostrea*In the absence of efﬁcient crystallization methods, the molecular structures of ﬁbrous assemblies have so far remained rather
elusive. In this paper, we present a rational method to crystallize the lanreotide octapeptide by modiﬁcation of a residue
involved in a close contact.
Indeed, we show that it is possible to modify the curvature of the lanreotide nanotubes and hence their diameter. This ﬁne
tuning leads to crystallization because the radius of curvature of the initially bidimensional peptide wall can be increased up
to a point where the wall is essentially ﬂat and a crystal is allowed to grow along a third dimension. By comparing X-ray
diffraction data and Fourier transform Raman spectra, we show that the nanotubes and the crystals share similar cell
parameters and molecular conformations, proving that there is indeed a structural continuum between these two morphologies.
These results illustrate a novel approach to crystallization and represent the ﬁrst step towards the acquisition of an Å-resolution
structure of the lanreotide nanotubes β-sheet assembly. Copyright © 2014 European Peptide Society and John Wiley & Sons, Ltd.
Additional supporting information may be found in the online version of this article at the publisher’s web site.
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Because of their implication in many human neurodegenerative
disorders such as Alzheimer’s, Parkinson’s, Huntington’s or prion
diseases, amyloid ﬁbres have spurred numerous studies [1].
Deciphering their structure and assembly mechanisms has been
a challenge to understand and hopefully prevent these diseases.
This comprehension is unfortunately intrinsically limited because of
their ﬁbrillar nature. Indeed, ﬁbres are generally one-dimensional
and non-crystalline objects, from which it is difﬁcult to get
structural information with traditional techniques such as X-ray
diffraction and high-resolution nuclear magnetic resonance (NMR)
spectroscopy. Fibre diffraction brings much less information than
that of a tridimensional single crystal and relies on an often delicate
processing of the ﬁbres to align them, either by shearing or by
application of an external electro-magnetic ﬁeld. Moreover, the
study of the pathological amyloid structures is also impeded
because their assembly is under kinetic control, which often results
in irreversibility and in a high degree of polymorphism [2–5]. In fact,
most of these issues are rather general to ﬁbrillar bioassemblies and
still today much work is devoted to determine or improve the
resolution of the structure of crucial structural proteins such as
collagen [6], actin [7], microtubules [8,9] and intermediary ﬁlaments
[10–12]. Likewise, the structures of elongated and rod-like viruses
have also been widely investigated [13–17].
In the speciﬁc case of amyloid ﬁbres, strategies using shorter
peptides have been set up to obtain high-resolution (~1 Å)
structures of the β-sheet amyloid ﬁbres. A method that proved
its worth consists in selecting short segments of ﬁbrils-forming
proteins such as synuclein [18], Sup35 [19,20], insulin [21],
amyloid-β [22] or αB-crystallin [23] and to crystallize them. Makabe508–516et al. [24] used the ‘link-and-cap’ strategy: they covalently linked a
deﬁned number of peptide units to prevent sample heterogeneity
and capped the extremities of the units to prevent further lateral
aggregation or lamination. These approaches allow determining
the atomic structure of individual elements such as elementary
β-strand building blocks and their further assembly into steric
zippers, but the full picture of the ﬁbrils remains elusive, especially be-
cause of their widespread polymorphism. More recently, Fitzpatrick
et al. reported the atomic-resolution (0.5Å) structures of three
polymorphic cross-β amyloid ﬁbrils formed by an 11-residue peptideCopyright © 2014 European Peptide Society and John Wiley & Sons, Ltd.
PEPTIDE CRYSTALLIZATION THROUGH CURVATURE CONTROL OF NANOTUBESusing a combination of NMR, cryo-EM, X-ray ﬁbre diffraction, STEM
and AFM [25]. Besides, this work illustrates that resolving a structure
remains a long-term endeavour and emphasizes the necessity to
combine several biophysical techniques to reach this goal.
In the present paper, we expose a crystallization approach that
consists in a minor chemical modiﬁcation carried out on a single
lateral side chain that does not modify the peptide packing but
allows the crystallization of the system. This approach has been
implemented on the lanreotide. Lanreotide is a synthetic octapep-
tide whose full sequence is detailed in the Material and Methods
section and whose extended formula is displayed in Figure 1A. Its
most speciﬁc chemical features are (i) a disulﬁde bond between
two cysteine residues that cyclizes the molecule and stabilizes a
hairpin conﬁguration; (ii) two cationic charges; (iii) three aromatic
residues segregated on one branch of the hairpin; (iv) two unnatu-
ral amino acids (D-naphthylalanine and D-tryptophan). These
features confer to the lanreotide peptide its remarkable self-assembly
properties in pure water. It has indeed been shown that when
the lanreotide-acetate salt is solubilized above a critical assembly
concentration of 20mM, it spontaneously self-assembles into
nanotubes with a strictly constant diameter of 24.4 nm [26,27].
The walls of these nanotubes are formed by a two-dimensional
crystalline bilayer. The stacking of the peptides in these two layers
is different (Figure 1A and B), but both are structured in one
direction by a H-bound network forming an antiparallel β-sheet
and in the other by close contacts between lateral chains, either
in the β-turn or at the N-terminus of the molecule. Finally, these
nanotubes are in a dynamic equilibrium with monomers and andFigure 1. Molecular packing of the lanreotide peptide in the nanotube walls
of the unit cell. The wall is made of two layers: (A) Outer layer of the nanotube
group of two lanreotide dimers (minimal building block of the wall, which deﬁ
red and aliphatic ones in blue. (D) Top view of a lanreotide nanotube section
inner layer and between the aliphatic residues (in blue) in the outer layer.
J. Pept. Sci. 2014; 20: 508–516 Copyright © 2014 European Peptide Society adimers [28], and they form a hexagonal columnar liquid crystalline
phase [26,27].
Several chemical modiﬁcations on the lanreotide amino acid
sequence and their consequences on the supramolecular assembly
have already been reported [29,30]. For example, opening the
lanreotide cyclic backbone either by replacing the cysteine by
alanines or by reducing the disulﬁde bridge with β-mercaptoethanol
leads to the formation of curved lamellae. Inverting the chirality
of the lysine residues from L to D conﬁguration leads to
formation of ﬁbres, while placing a D-phenylalanine instead of
the D-naphthylalanine or of the L-tyrosine leads to the formation
of micelles. In another case, the deletion of the D-tryptophan
residue totally prevents self-assembly. These modiﬁcations clearly
underline the speciﬁcity of the amino acids sequence leading to
the assembly of well-deﬁned monodisperse nanotubes.
More interestingly, it was also demonstrated that the slight
modiﬁcation of the side chain of a single residue involved in a
steric close contact allowed for the ﬁne tuning of the diameter
of the nanotubes [31]. Indeed, replacing the D-tryptophan in
the fourth position by aromatic residues of different size allows
creating a library of peptides forming nanotubes of diameters
ranging from 10 to 36 nm. This was explained by a simple
geometrical model (Figure 1C and D) showing that the nanotubes
diameter is proportional to the size of the aromatic side chains
because these latter are involved in a close contact localized in
the inner layer of the nanotube wall (Figure 1B).
Additionally to such chemical modiﬁcations, counter-ions can
also be used to induce morphological changes in supramolecularand corresponding geometrical model based on the simpliﬁed projection
wall and (B) inner layer of the nanotube wall. (C) Schematic top view of a
nes its thickness). The hydrophobic surfaces are in green, aromatic ones in
highlighting the close contacts between aromatic residues (in red) in the
nd John Wiley & Sons, Ltd. wileyonlinelibrary.com/journal/jpepsci
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0assemblies [32–36]. In the particular case of lanreotide nanotubes,
we have previously shown that both diameter and number of walls
can be modulated by using counter-ions of respectively different
sizes [37] and valences [38].
The observation of the molecular packing of the lanreotide
monomers in the nanotubes suggests that close contacts
between aliphatic residues of adjacent dimers may also exist. In
particular, the lysine side chain could be involved in such close
contacts, this time in the outer layer of the peptide wall (Figure 1A),
contrary to the aforementioned close contacts observed between
aromatic residues. We thus expect that a size modiﬁcation on this
location would also contribute to change the nanotube diameter,
but that this effect would be the opposite. Indeed, as the geometric
model previously devised [31] suggests it (Figure 1C and D), the
curvature of the nanotubes should increase when the local steric
hindrance decreases. In the present work, we therefore probed
the inﬂuence of the aliphatic side chain length of the amino acid
residue in position 5. We used transmission electron microscopy
(TEM), small angle X-ray scattering (SAXS), Fourier transform Raman
and Fourier transform infrared (FTIR) spectroscopies to characterize
the structures of the corresponding peptide assemblies.Results
Inﬂuence of the Lysine Side Chain Length
The inﬂuence of the aliphatic side chain of the amino acid residue
in position 5 was probed by synthesizing lanreotide derivatives
with L-dimethyl-lysine, L-ornithine, L-1,4-diamino-butyric acid or
L-1,3-diamino propionic acid, instead of the L-lysine (Materials
and Methods section). We will refer to the corresponding derived
peptides respectively as derivative 1, 2, 3 and 4 (Table 1).
These peptides were solubilized at room temperature in pure
water at concentrations above 20mM. The derivatives 1, 2 and 3
form translucent gels similar to the one obtained with lanreotide.
A negatively stained transmission electron micrograph of a deriva-
tive 3 sample – but representative of these three derivatives – isTable 1. Nomenclature of the peptide studied in the paper and
analysis of SAXS patterns
Name of the peptide Residue in position 4 Side ch
i
Lanreotide (L) L-lysine
Derivative 1 L-dimethyl-lysine
Derivative 2 L-ornithine
Derivative 3 L-1,4-diamino-butyric acid
Derivative 4 L-1,3-diamino propionic acid
aThe length of the extended aliphatic chain was determined usi
wileyonlinelibrary.com/journal/jpepsci Copyright © 2014 European Pedisplayed in Figure 2A. It shows that the gels are formed of self-as-
sembled peptide nanotubes. This nanotube structure is conﬁrmed
by the typical oscillations of the SAXS patterns displayed in
Figure 2C (Traces L and 1–3). Indeed, these oscillations can be ﬁtted
by normalized Bessel functions of zeroth order [J0(q*r0)/q]
2 that are
the theoretical form factors of inﬁnite hollow cylinders [39]. The
nanotubes radius r0 can thus be extracted from this mathematical
model, while the high number of oscillations (more than ten) gives
an indication of the very low polydispersity. We give the corre-
sponding diameters for each peptide in Table 1. Moreover, the
three reﬂections between 0.35 and 0.37Å1 corresponding to
repetitive distances between 17 and 18Å can be assigned to a
β-sheet network resulting from an alternated stacking of antiparallel
peptides (Figure 1A and Valéry et al. [26]). The FTIR spectra in the
amide I region (Figure 2D) support this interpretation. Indeed,
the bands at 1694 and 1614 cm1 are the characteristic features
of antiparallel β-sheets. Moreover, all the spectra display bands
attributed to a turn (1664 cm1) and to a random conformation
at 1640 cm1. All these features were previously observed and
interpreted in details for the lanreotide peptide nanotubes [26,27].
In the case of the derivative 4, some polymorphism is
observed. If the peptide powder is solubilized at room temperature,
a milky liquid is instantaneously obtained, whereas if solubilization
occurs at 70 °C, a transparent gel forms after cooling down to room
temperature. SAXS data (Figure 2C, trace 4) demonstrate that this
gel is made of 31.4-nm wide nanotubes. Depending on the TEM
sample preparation, other morphologies such as ﬁlaments or some
sparse microcrystals may be observed (Figure S1). TEM observa-
tions of the milky liquid obtained at room temperature reveal that
it is actually a suspension of micron-size needle-shaped crystals
that scatter light (Figure 2B) and are dense enough to the electrons
to be imaged without staining (Figure S1A). The X-ray powder
diffraction pattern of such a sample (Figure 2D, trace 4*) conﬁrms
the crystalline nature of these objects. The diffraction peaks were
indexed in a monoclinic cell. The full indexation of the peaks is
reported in Table 2 and the corresponding cell parameters in
Table 3. These parameters are very close to those of the 2D cellsdiameters of the corresponding nanotubes as measured by
ain of the residue
n position 4
Length of the aliphatic
chaina (Å)
Nanotube
diameter (nm)
8.3 24.4
8.4 25
7.1 25.7
5.8 27.3
4.6 31.4/crystals
ng ChemDraw.
ptide Society and John Wiley & Sons, Ltd. J. Pept. Sci. 2014; 20: 508–516
Figure 2. Inﬂuence of the lysine side chain length on the peptide assembly. (A) Negatively stained electron micrographs of derivative 3. Scalebar= 100nm.
(B) TEM micrograph of derivative 4 microcrystals in water. Scalebar =1μm. (C) SAXS proﬁles of the lanreotide (trace L) and of the four lysine-modiﬁed
derivatives. For the derivative 4, proﬁles corresponding to the both nanotubes (4) and crystals (4*) forms are shown. The grey arrows points out the reﬂection
at 0.35Å1 indicative of an antiparallel β-sheet network (refer to main text for details). (D) ATR-FTIR spectra of lanreotide and four derivatives.
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1of the nanotubes [26]. It is thus very likely that 2D peptide walls are
piling up to form 3D crystals, albeit with a slight deformation. As
the correlation length estimated from the full width at half-max-
imum of the diffraction peaks (ξ = 2π/Δq) is only 56 nm long –
which is rather small compared to the dimensions measured
on the micrographs – we cannot discard the possibility that
the crystals are twinned. FTIR spectrum of the centrifuged pellet
appears slightly more deﬁned than that of previous one.
Although characteristic vibrations due to antiparallel β-sheet are
present, new vibrations are detected at 1653 and 1678 cm1. On
the contrary, the comparison of the FT-Raman spectra of the
lanreotide nanotubes and of the derivative 4microcrystals suggests
that the conformation of the aromatic residues is similar in both
structures (Figure 3).
Indeed, Raman spectroscopy is commonly used to provide
information on structural features of peptide and proteins as
secondary structures and markers of side chain environments
[40–42]. Here, the Raman spectra provide ﬁngerprints of the
aromatic side chains environment of lanreotide within each
assembly. The full spectra of the lanreotide nanotubes (top
spectrum) and of the centrifuged microcrystals of derivative 4
(bottom spectrum) are presented in Figure 3. The main peaks can
be assigned to the aromatic residues (D-tryptophan, L-tyrosine
and D-naphthylalanine). Because of the presence of these three
aromatic residues, overlaps may exist, and therefore we do not give
detailed assignations of the full spectra. Some other peaks are dueJ. Pept. Sci. 2014; 20: 508–516 Copyright © 2014 European Peptide Society ato the disulﬁde bridge (495–525 cm1) and to the β-sheet confor-
mation (1640–1700 cm1). Most of these peaks are common in
the two spectra, indicating that the side chains conformations are
similar in both the nanotubular and the microcrystalline forms. In
particular, the very intense peaks assigned to tryptophane side
chains (W18: 768.8 cm1, W16: 1013.7 cm1, W15: 1085.06 cm1,
W7: 1382.08 cm1, W6: 1438.01 cm1) or tyrosine (631.81 and
1613.53 cm1) are indeed found in the same position in both
spectra indicating a very close environment of tryptophan in both
nanotubes and crystals. Slight differences can be observed
between the two spectra (Figure 3, pointed out with ≠), mostly
in wavenumbers ranges assignable to tyrosine (820–850 and
1210–1180 cm1). However, these differences occur with peaks
of low intensity whose signal can be mingled with noise, so
these differences are probably marginal.Discussion
In the present work, we show that the decrease of the aliphatic
chain length of the L-lysine (i.e. the amino acid in the position 5 of
the lanreotide sequence) leads to the formation of self-assembled
peptide nanotubes of increasing diameter from 24.4 to 31.4 nm.
The wall of the lanreotide nanotube is made from a bilayer, both
layers being formed by the lateral association of antiparallel β-sheet
protoﬁlaments. The close contacts between the protoﬁlaments arend John Wiley & Sons, Ltd. wileyonlinelibrary.com/journal/jpepsci
Table 2. Peak indexation of the diffraction pattern exhibited in
Figure 2C (trace 4*)
Miller indices hkl qth qexp Error
1 0 0 0.3235 0.3234 1.104
1 0 –1 0.3554 0.3545 9.104
1 1 0 0.4979 0.4972 7.104
1 0 1 0.5370 0.5399 3.103
2 0 1 0.5994 0.5972 2.103
2 0 0 0.6470 0.6460 1.103
1 1 1 0.6570 0.6578 8.104
2 1 1 0.7089 0.7083 6.104
2 –1 0 0.7496 0.7485 1.103
0 2 1 0.8220 0.8215 6.104
1 1 2 0.9059 0.8914 1.102
2 1 1 0.9052 0.9099 8.104
1 2 1 0.9281 0.9279 2.104
3 0 0 0.9705 0.9683 2.103
3 1 0 1.0417 1.0395 2.103
2 0 2 1.0740 1.0786 5.103
2 2 1 1.1209 1.1207 2.104
0 3 0 1.1355 1.1355 3.105
3 1 1 1.1962 1.2000 4.103
0 –2 3 1.2236 1.2290 5.103
1 3 1 1.2561 1.2544 2.103
0 0 4 1.2818 1.2816 2.104
2 3 0 1.3069 1.3060 9.104
2 2 2 1.3140 1.3182 4.103
3 1 –4 1.3252 1.3278 3.103
2 3 –2 1.3397 1.3467 7.103
1 2 3 1.3583 1.3649 7.103
3 1 2 1.4078 1.4135 6.103
2 3 3 1.4650 1.4655 9.104
0 3 3 1.4878 1.4829 5.104
4 1 1 1.4981 1.4973 5.103
0 4 0 1.5140 1.5119 9.104
5 0 –3 1.5249 1.5314 2.103
1 4 –1 1.5530 1.5544 6.103
5 0 0 1.5552 1.5544 1.103
4 2 1 1.6353 1.6352 1.104
3 1 3 1.6548 1.6519 3.103
4 1 2 1.6960 1.6983 2.103
Average error 3.103
Maximum error 1.102
Not observed qth
0 0 1 0.3205
0 1 0 0.3785
0 0 2 0.6409
0 2 0 0.7570
4 0 0 1.2940
0 0 5 1.6023
Table 3. Unit cell parameters of the nanotubes walls and of the c
a (Å) b (Å)
Lanreotide NT (2D crystal)a 20.7 —
Derivative 4 (crystals) 21.1 16.6
aCell parameters taken from Valéry et al. [26].
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2provided by the D-tryptophan for the inner layer and by L-lysine for
the outer one [31]. In a previous work, we have shown that
increasing the steric hindrance of the amino acid providing the
close contact between protoﬁlaments in the inner layer, that is,
the D-tryptophan, increases the nanotube diameter from 24.4 to
31.4 nm. This ﬁne diameter tuning was explained and predicted
by a simple geometrical model [31]. By using the same model,
the increase of the diameter by the decrease of the steric
hindrance of the close contacts on the outer layer, that is, the
amino acid in position 5, is also predicted, as illustrated in
Figure 4A. The equation 1 is deduced from the model (refer to
Supporting Information):
δi ¼ f  Fð Þ  2F e
Di
(1)
F and f are the distances between two close contacts in the outer
and inner layers respectively and e the thickness of the bilayer
that constitutes the nanotube wall. These parameters are
illustrated in Figure 1C. For the present experiments, δi has been
estimated using Chemdraw to measure the length of the different
lateral chains introduced in position 5 (Table 1).
On Figure 4B (triangles), the plot of δi as a function of the
inverse of the nanotubes diameter exhibits a linear evolution with
a positive slope as expected from Eqn 1. However, the structural
parameters f, F and e (extracted from the origin and slope of the
straight line) are different from the values known from the
structural model [31]. This misﬁt can be ascribed to the discrepancy
between our values of δi measured for fully extended aliphatic
chains and the real values δi for ﬂexible chains. Nevertheless, these
experiments extend the validity of the geometrical model to the
close contacts present on the outer layer of the nanotubes walls.
A molecular steric modiﬁcation of the order of the ångström
(length of the lysine side chain) therefore leads to modiﬁcations
of the diameter dimension of the order of the nanometre. Here,
one must point out that this change of diameter comes with an
accommodation of the number of molecules in the perimeter
so that the environment of the close contacts that are untouched
by the chemical modiﬁcation does not change.
In addition to the present data, we have plotted on Figure 4B
most of the data from Tarabout et al. [31] (diamonds) and
Gobeaux et al. [37] (circles). The ordinate reads the ‘normalized’
hindrance of the modiﬁcations, whether it is a chemical modiﬁcation
of the aromatic residue in position 4 (open diamonds), on the
aliphatic residue on position 5 (triangles) or a change of counter-
ions (circles). We have chosen the lanreotide-acetate condition as
a reference (δi=0, D=24.4 nm, 1/D=0.041 nm
1).
Comparing the slopes of the plots of these three sets of data
corresponding to the three possible ‘triggers’ may give us insight
on the strength of each lever arm to control the nanotubes
diameter. In this respect, the most efﬁcient ‘trigger’ appears to
be the aromatic residue in the position 4, while the respective
effects of changing the counter-ions or modifying the length ofrystals
c (Å) α (°) β (°) γ (°) V (Å3)
20.8 — 119 — 7000
21.3 90 113 90 6870
ptide Society and John Wiley & Sons, Ltd. J. Pept. Sci. 2014; 20: 508–516
Figure 3. FT-Raman comparison of nanotubular and microcrystalline
forms. (A) FT-Raman spectra of 10%w/w lanreotide nanotubes gel (top
graph) and of centrifuged microcrystals of derivative 4 (bottom graph).
The symbols ‘*’ and ‘≠’ respectively indicate similar and differing peaks.
PEPTIDE CRYSTALLIZATION THROUGH CURVATURE CONTROL OF NANOTUBESthe aliphatic side chain on position 5 are of the same order of
magnitude. Indeed, when a 1-Å modiﬁcation is introduced on the
position 4, the nanotubes diameter changes on average of
10.2 nm, whereas a 1-Å modiﬁcation is introduced on the position
5, the diameter only changes of 1.7 nm. The lesser strength of the
aliphatic lever armmay be explained by the fact that the molecular
packing is slightly less dense in the outer layer than in the inner
layer. Additionally, the close contacts between aliphatic residues
may be less rigid than between aromatic ones.Figure 4. (A) Geometrical illustration of the formation of crystals as a limit-c
drance (symbolized by blue beads) of the close contacts in the outer layer is
δi/relative for each ‘trigger’ as a function of the inverse of the measured diamet
δ=0 for the lanreotide-acetate condition (located at the centre of the cross-h
lanreotide; the red diamonds (◊) to the modiﬁcations of the aromatic resid
aliphatic side chain on position 5. The lines are guides to the eye, and the gre
diagram colligates data from this study and from references [31,37]. NB: The d
chain has been acetylated. This derivative self-assembles into nanotubes of 1
previously published in Gobeaux et al. [37].
J. Pept. Sci. 2014; 20: 508–516 Copyright © 2014 European Peptide Society aFigure 4B also illustrates that the three triggers do not have the
same range of application. Modiﬁcations of the aromatic residue
on position 4 allows for a wide range of diameters from 10 to
36nm, whereas the counter-ions exchange provides a ﬁner tuning
in the 19–26-nm range. Modiﬁcations of the aliphatic residue on
the position 5 ‘ﬁll the gap’ in the 26–32-nm range. Moreover, the
‘counter-ion trigger’ can basically be used on any molecule. One
can thus envision reaching an even ﬁner tuning of the nanotubes
diameter by using the three triggers on a single molecule.
Finally, at the y-intercept the model gives theoretical values of δi
for which the curvature of the nanotubes becomes ﬂat, because the
diameter D tends to inﬁnity. According to the experimental results, it
seems that the span of the nanotube diameter range is upper
bounded by a value of the order of 30–35 nm. Indeed, above this
boundary, we rather observe crystals than nanotubes. This ‘crys-
tallization zone’ is coloured in light grey in Figure 4B.
As a matter of fact, our study does suggest that there is a
structural continuum between the nanotubes and the crystals
and that the latter are a borderline case when the radius of
curvature becomes very large. Indeed, X-ray diffraction reveals that
both 2D and 3D crystals are made of monoclinic cells (Table 3). The
parameters a and c correspond to the parameters of a bilayer cellase when the radius of curvature tends to inﬁnite because the steric hin-
getting smaller. (B) Plots of the characteristic dimensions of the hindrance
ers in accordance to the geometric model. The δi have been scaled so that
air). Black open circles corresponds to the counter-ions exchanges on the
ue on position 4 and the blue triangles (Δ) to the modiﬁcations on the
y area indicates the region where we experimentally observe crystals. This
atapoint tagged 0 corresponds to a lanreotide derivative whose lysine side
9.9-nm diameter. The complete characterization of this peptide has been
nd John Wiley & Sons, Ltd. wileyonlinelibrary.com/journal/jpepsci
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4while the parameter b=16.6Å, which is slightly lower than the 18Å
in the lanreotide nanotube cell, represents the thickness of a dimer.
Four peptides can ﬁt in the volume V=6870Å3, which corresponds
to two dimers attached by hydrogen bonds. The symmetry ele-
ments due to the monoclinic cell suggest that the dimers are
exactly piled on top of each other along the third direction
without any position inversion between the hydrophilic zones. This
means that the elements constitutive of the outer layer in the
nanotubes are directly superimposed on the elements constitutive
of the inner layer in the nanotubes. As a consequence, there is a C2
symmetry axis along b, perpendicularly to the dimer thickness,
oriented in the same direction as in the lanreotide nanotube layers.
Additionally, the Raman spectra of the two forms exhibit very
similar ﬁngerprints (Figure 3). The differences observed in the
ATR-FTIR spectra might simply be attributed to the high sensitivity
of the technique to vibratory modes which obviously change when
the curvature becomes ﬂat.
Actually, we have found similar borderline cases with the other
triggers, which will be reported elsewhere with complete struc-
tural details. Notwithstanding, the fact that all these crystallizing
samples were part of series of samples with increasing nanotubes
diameters emphasizes the generality of the approach. In some
cases, depending on the followed kinetics path, both forms can
be observed for the same physical–chemical condition.
A future perspective for this study is to obtain diffraction
patterns of the crystals. We can consider using a microfocus
beam [43], whose 5-μm diameter may allow to shine X-ray on a
single small crystal such as the ones exhibited in Figure 2B. We
can also try to grow larger crystals by slowing down nucleation
or by using our current crystals as seeds so as to perform more
conventional diffraction experiment. Because peptides are small
compared to proteins, a single crystal contains many more unit
cells, and thus, we expect to reach a very high resolution, of the
order of the ångström [19–22]. The detailed structure of the
crystals with such a resolution would bring new and accurate
informations on the interactions at the origin of the singular assembly
of lanreotide and on the exact orientation of the aromatic resi-
dues in the layers. It would also give more insights on the origin
of the interactions between the stacked bilayers that allow for
the growth of the crystals along the b-axis.Conclusion
Overall, the present results along with those of previous work
[31,37] show that lanreotide nanotubes formation is a robust
process that can withstand to a certain extent chemical modiﬁcations
of carefully chosen amino acids in the sequence (i.e. D-tryptophan on
the fourth position and L-lysine on the ﬁfth position) or exchange of
the counter-ions. These approaches allow the tuning of the diameter
of lanreotide nanotubes in the 10-36-nm range and lead tomolecular
crystallization. This may represent a ﬁrst step towards the determina-
tion of the atomic structure of lanreotide nanotubes.Materials and Methods
Materials
Lanreotide was obtained from Ipsen Pharma (Barcelona, Spain),
and the derivatives were synthesized by solid-phase Fmoc/tBu
chemistry. The peptide chain was ﬁrst assembled and then cyclized
on-resin. Cleavage and side chain deprotection were performedwileyonlinelibrary.com/journal/jpepsci Copyright © 2014 European Pesimultaneously, followed by puriﬁcation and counter-ion exchange
[37,44]. Purity of the ﬁnal products was checked by HPLC/MS (refer
to the following text and Supporting Information). Peptide
sequences are lanreotide: H-D-2-Nal1-cyclo(Cys2-Tyr3-D-Trp4-Lys5-
Val6-Cys7)-Thr8-NH2; derivative 1: H-D-2-Nal
1-cyclo(Cys2-Tyr3-D-
Trp4-(Me)2Lys
5-Val6-Cys7)-Thr8-NH2; derivative 2: H-D-2-Nal
1-cyclo
(Cys2-Tyr3-D-Trp4-Orn5-Val6-Cys7)-Thr8-NH2; derivative 3: H-D-2-
Nal1-cyclo(Cys2-Tyr3-D-Trp4-Dab5-Val6-Cys7)-Thr8-NH2; derivative 4:
H-D-2-Nal1-cyclo(Cys2-Tyr3-D-Trp4-Dap5-Val6-Cys7)-Thr8-NH2LC/MS Analysis and Puriﬁcation
HPLC was performed using a Waters system (2525 binary gradient
module, in-line degasser, 2767 sample manager, 2996 Photodiode
Array Detector). The eluent was a gradient of A (99.9% water/0.1%
HCOOH) and B (99.9% ACN/0.1% HCOOH). Either analytical or
preparative X-bridge C18 columns were used. Retention times (rt)
are given in Table S1.
The mass spectrometer was a Waters Micromass ZQ system with
a ZQ2000 quadrupole analyser. The ionization was performed by
electrospray, and the other parameters were as follows: source
temperature 120 °C, cone voltage 20V and continuous sample
injection at 0.3ml/min ﬂow rate. Mass spectra were recorded in
positive ion mode in the m/z 100–2000 range and treated with
the Mass Lynx 4.0 software. The experimental and calculated m/z
are given in Table S1.NMR Analysis
The synthesized peptides were controlled by 1HNMR on a Bruker
Avance 400 Ultrashield. Spectra were recorded at room temperature
at 400MHz, and samples were dissolved in D2O at a concentration of
approximately 5mM. The D2O singlet signal was set up at 4.79ppm.
Chemical shifts are given in ppm and the coupling constants in
Hz. The full characterizations are given in the Supporting Infor-
mation text.Transmission Electron Microscopy
Transmission electron microscopy was performed on a Philips
CM12 electron microscope operated at 80 kV. A drop of the
solution at 3–5%w/w was put on a copper grid covered with a
carbon ﬁlm (Agar Scientiﬁc). After blotting off of the excess liquid,
the material was stained with a 2% uranyle acetate solution.Small Angle X-ray Scattering
Small angle X-ray scattering experiments were either performed
at the SWING beamline at the SOLEIL synchrotron (Saclay, France)
or with a rotating anode laboratory set-up. X-ray patterns were
detected and recorded via a CCD (chip charge-coupled device)
camera detector. The samples were inserted in 1.3–1.6-mm round
glass capillaries and centrifuged at the bottom. The scattering
intensities as a function of the radial wave vector, q=4π/λ × sinθ,
were determined by circular integration and tubes diameter
were, when present, estimated by ﬁtting the corresponding oscil-
lations by normalized zeroth order Bessel functions J0
2(q.r0)/q
2
(Oster and Riley [39]). When the sample was crystalline, the
powder diffraction Bragg peaks were simulated and indexed with
McMaille [45].ptide Society and John Wiley & Sons, Ltd. J. Pept. Sci. 2014; 20: 508–516
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5Fourier Transform Infrared Spectroscopy
Attenuated total reﬂectance Fourier transform infrared (ATR-FTIR)
spectra were recorded at a 2-cm1 resolution with a Bruker IFS 66
spectrophotometer equipped with a 45° N ZnSe ATR attachment.
The spectra obtained resulted from the average of 30 scans and
were corrected for the linear dependence on the wavelength of
the absorption measured by ATR. The water signal was removed
by subtraction of pure water spectrum. Analysis of the conforma-
tions of the peptides was performed by deconvolution of the
absorption spectra as a sum of Gaussian components with PeakFit
4.12 (Seasolve Software Inc.).
Fourier Transform Raman Spectroscopy
Fourier transform Raman spectroscopywas performed on the same
capillaries as used for SAXS characterization. The spectra were
recorded at 4-cm1 resolution using a Bruker IFS66 interferometer
coupled to a Bruker FRA106 Raman module equipped with a
continuous Nd:Yag laser providing excitation at 1064 nm.
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